AnaptysBio, Inc. <ANAB.O>: TD Cowen cuts target price to $70 from $75
ANAB•Related News
Gold retreats from three-month high as investors await US inflation data
GLD•
Global markets-Asia shares fall on tech nerves; oil prices slip
SPY•
Palantir Chief Accounting Officer Jeffrey Buckley disposes of $576,526.44 in common shares
PLTR•
Nasdaq trade halt REAX.O halt news pending at 07:50 PM
REAX•
Sherwin-Williams Co <SHW.N>: D.A. Davidson initiates coverage with buy rating; target price $400
SHW•